 Nov 1 2022
Recent article published in Molecular Oncology with MedRod速 implants i...
|
 |
| PRICE QUOTE AND TECHNICAL INQUIRIES |
FOLLOW US
 |
|
|
MedRod速, a hormone implantRegistered trademark developed by Preclinapps
MedRod速 implant delivers active ingredient in efficient and reliable manner to support and improve the quality of preclinical studies. It is stable and cost-effective substitute to chronic injections.MedRod速 dosing technology for preclinical animal research
In MedRod速 implant the active compounds are dispersed in flexible, polymeric cylindrical rods, optionally covered by membrane or coating. The process results in elastic MedRod速 where compound is safely immobilized and steadily released for several months. MedRod速 implants are intended for in vitro or in vivo preclinical studies.
MedRod速 implants have been validated with several immunodeficient mouse strains, including athymic nude, NOG, NSG, balb/c nude and SCID mice as well as with many hormone-dependent breast and prostate cancer cell lines such as, MCF-7, BT-474 and LNCaP cells. Ask free consultation for your model.
|  | What is MedRod速, where is it been used- Long-term drug release from a week to years
- typically used in ER and AR-dependent xenograft, syngeneic and PDX cancer studies and metabolic studies in mice, but also in rats or even larger animals (dog, minipig)
- Estrogens, androgens, progestins, glucocorticoids and other small molecules (such as 17beta estradiol, DHT, testosterone)
- Dose range from 10 ng/day even up to 200 mcg/day
- Elastic and biocompatible soft matrix
- Each batch and dosage validated unlike competing long-term drug delivery systems
| |
Updated
24 June, 2022
| | |
|
